ArticleSignal transduction and targeted therapy2022

Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT.

Jia Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.